Benzinga's Volume Movers

Retrophin, Inc. RTRX shares climbed 4.07% to $20.99. The volume of Retrophin shares traded was 2261% higher than normal. Retrophin priced a public offering of 6.84 million shares of common stock at $19 per share. Amicus Therapeutics, Inc. FOLD surged 28.13% to $11.98. The volume of Amicus Therapeutics shares traded 2064% higher than normal. Amicus Therapeutics announced positive global regulatory updates from the EMA and the FDA meetings for Fabry monotherapy. Esperion Therapeutics, Inc. ESPR shares moved up 9.18% to $115.42. The volume of Esperion Therapeutics traded was 1092% higher than normal. Esperion Therapeutics announced the pricing of 1.75 million share offering at $100.00 per share. Guess?, Inc. GES shares rose 16.19% to $19.45. The volume of Guess' shares traded was 1012% higher than normal. Guess reported stronger-than-expected earnings for its fourth quarter.